SavedAdd your journal

Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2020 / Cilt: 28 - Sayı: 2

Renoprotective effect of edaravone in acute limb ischemia/reperfusion injury

Akut alt ekstremite iskemi-reperfüzyon hasarında edaravonun renal koruyucu etkisi

İlker AKAR
İlker İNCE
Akgül ARICI
Pages
274–281
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it can be used toameliorate acute ischemia/reperfusion injury during aortic andperipheral vascular surgery

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: In this experimental study, we aimed to investigatethe efficacy of edaravone on renal injury due to acute lower limbischemia/reperfusion in a rat model.Methods: Between June 2015 and August 2015, a total of40 male Wistar rats were used in this study.
📊
Key Findings & Data:The rats wererandomly divided into the sham, ischemia/reperfusion,edaravone, and solvent groups (n=10 in each).
💡
Conclusion & Impact:Therefore, it can be used toameliorate acute ischemia/reperfusion injury during aortic andperipheral vascular surgery
🔬Design:Modeling & Simulation
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: In this experimental study, we aimed to investigatethe efficacy of edaravone on renal injury due to acute lower limbischemia/reperfusion in a rat model.Methods: Between June 2015 and August 2015, a total of40 male Wistar rats were used in this study. The rats wererandomly divided into the sham, ischemia/reperfusion,edaravone, and solvent groups (n=10 in each). The infrarenalabdominal aorta was clamped for 120 min and was, then,reperfused for 120 min after clamp removal. Edaravone wasadministered intravenously 30 min before the induction ofischemia. Serum and kidney tissue samples were subjected tobiochemical and histopathological analyses.Results: Edaravone decreased the serum and tissuemalondialdehyde levels in the ischemia/reperfusion group. Theserum superoxide dismutase activity in the edaravone group wassignificantly higher than the ischemia/reperfusion and solventgroups. The serum nitric oxide level in the ischemia/reperfusiongroup was numerically higher than the sham group. The serumnitric oxide level was decreased by edaravone. The serum nitricoxide level was lower in the edaravone group than the solventgroup. The tissue nitric oxide level was significantly higher inthe ischemia/reperfusion than the sham group. In the ischemia/reperfusion group, the histopathological changes were improvedby edaravone.Conclusion: Edaravone ameliorated renal injury caused bylower-limb ischemia/reperfusion. Therefore, it can be used toameliorate acute ischemia/reperfusion injury during aortic andperipheral vascular surgery

Özet

Amaç: Bu deneysel çalışmada, sıçan modelinde akut alt ekstremite iskemi/reperfüzyonuna bağlı böbrek hasarında edaravonun etkinliği araştırıldı. Ça­lış­ma pla­nı: Bu çalışmada Haziran 2015 - Ağustos 2015 tarihleri arasında toplam 40 erkek Wistar sıçan kullanıldı. Sıçanlar sham, iskemi/reperfüzyon, edaravon ve solvent gruplarına randomize edildi (n=10 her bir grupta). İnfrarenal abdominal aort 120 dk. süreyle klemlendi ve sonrasında klemp kaldırılarak 120 dk. reperfüze edildi. İskemi indüksiyonundan 30 dk. önce edaravon intravenöz olarak verildi. Serum ve böbrek doku örnekleri biyokimyasal ve histopatolojik olarak analiz edildi. Bulgular: Edaravon serum ve doku malondialdehit düzeylerini iskemi/reperfüzyon grubunda azalttı. Serum süperoksit dismutaz aktivitesi, iskemi/reperfüzyon ve solvent gruplarına kıyasla, edaravon grubunda anlamlı düzeyde yüksekti. Serum nitrik oksit düzeyi iskemi/reperfüzyon grubunda, sham grubuna kıyasla, rakamsal olarak yüksek bulundu. Edaravon serum nitrik oksit düzeyini düşürdü. Serum nitrik oksit düzeyi edaravon grubunda, solvent grubundan, daha düşük idi. Doku nitrik oksit düzeyi iskemi/reperfüzyon grubunda, sham grubundan, anlamlı düzeyde daha yüksek idi. İskemi/ reperfüzyon grubunda histopatolojik değişikliklerde edaravon ile düzelme görüldü. So­nuç: Edaravon alt ekstremite iskemi/reperfüzyonuna bağlı renal hasarı azalttı. Bu nedenle, aort ve periferik damar cerrahisinde akut iskemi/reperfüzyon hasarını hafifletmede kullanılabilir.

🔖

Cite This Article

AKAR, İ., İNCE, İ., ARICI, A. (2022). Renoprotective effect of edaravone in acute limb ischemia/reperfusion injury. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 28 - Sayı: 2, 274–281. https://ajindex.com/articles/423615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gülmen Ş, Doğuç Kumbul D, Ceylan Gökçe B, Çetin Kahraman N, Meteoğlu İ, Okutan H, et al. The effect of betaglucan on kidney injury in experimental aortic ischemiareperfusion. Turk Gogus Kalp Dama 2011;19:234-41
  2. Mansour Z, Charles AL, Kindo M, Pottecher J, ChamarauxTran TN, Lejay A, et al. Remote effects of lower limb ischemia-reperfusion: impaired lung, unchanged liver, and stimulated kidney oxidative capacities. Biomed Res Int 2014;2014:392390
  3. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 1989;20:1236-40
  4. Abe T, Unno M, Takeuchi H, Kakita T, Katayose Y, Rikiyama T, et al. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. J Gastrointest Surg 2004;8:604-15
  5. Masaki Y, Kumano K, He N, Suyama I, Endo T. Protective effects of MCI-186 on cold kidney preservation/reperfusion injury in the rat. Transplant Proc 1996;28:1885-6
  6. Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004;65:1714-23
  7. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail 2009;31:70-4
  8. Kikuchi K, Tancharoen S, Takeshige N, Yoshitomi M, Morioka M, Murai Y, et al. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci 2013;14:13909-30
  9. Tabrizchi R. Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs 2000;1:347-54
  10. Zhou S, Yu G, Chi L, Zhu J, Zhang W, Zhang Y, et al. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Neurotoxicology 2013;38:136-45
  11. Kassab AA, Aboregela AM, Shalaby AM. Edaravone attenuates lung injury in a hind limb ischemia-reperfusion rat model: A histological, immunohistochemical and biochemical study. Ann Anat 2020;228:151433
  12. Yamamura M, Miyamoto Y, Mitsuno M, Tanaka H, Ryomoto M. Pretreatment with the Free Radical Scavenger Edaravone Mitigates Kidney Glycogen Depletion and Neutrophil Infiltration after Leg Ischemia in a Rat Model: A Pilot Study. Ann Vasc Dis 2017;10:417-22
  13. Ito K, Ozasa H, Horikawa S. Edaravone protects against lung injury induced by intestinal ischemia/reperfusion in rat. Free Radic Biol Med 2005;38:369-74.